Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
08/01/2012 | CN102617589A Artificial antigen for aflatoxin M1 and antibody prepared by same |
08/01/2012 | CN102617516A Albuterol artificial antigens and antibodies prepared by same |
08/01/2012 | CN102617493A Mequindox artificial antigens and antibodies prepared by same |
08/01/2012 | CN102614510A Yeast-based therapeutic for chronic hepatitis C infection |
08/01/2012 | CN102614506A Recombinant HPV16L2 protein vaccine and preparation method thereof |
08/01/2012 | CN102614499A Yak skin collagen compound traditional Tibetan medicine with anti-fatigue effect and preparation process thereof |
08/01/2012 | CN102614219A Method for preparing human prothrombin complex with high yield |
08/01/2012 | CN102174524B Liparis nervosa lectin gene and protein as well as application thereof |
08/01/2012 | CN101870979B Insecticidal gene cryX with high toxicity to lepidopterous pests and application thereof |
08/01/2012 | CN101816784B Immunoprotective subunit vaccine, preparation method thereof and application method thereof |
08/01/2012 | CN101798576B Encoding sequence for Late Embryogenesis Abundant protein of Jatropha curcas and application in plants |
07/31/2012 | US8232379 Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence |
07/31/2012 | US8232374 Method for decreasing biomass-biomass interactions or biomass-resin interactions |
07/31/2012 | US8232373 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
07/31/2012 | US8232371 Modified human interferon polypeptides and their uses |
07/31/2012 | US8232370 Antimicrobial protein specific to Staphylococcus aureus |
07/31/2012 | US8232258 NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and variants thereof, and their use |
07/31/2012 | US8232255 Methods for vaccinating against malaria |
07/31/2012 | US8232252 Immunoglobulin/bone morphogenic protein fusion for treatment and prevention of inflammatory disorders |
07/31/2012 | US8232244 Supplying cargo compound into cancer cells; cargo compound may be nucleic acids, Dna, Rna |
07/31/2012 | US8232101 Identification of antigenic peptides from multiple myeloma cells |
07/31/2012 | US8232078 Methods of using improved polymerases |
07/31/2012 | US8232076 Neurogenin |
07/31/2012 | US8232063 H+-gated ion channel |
07/31/2012 | US8232060 Gene defects and mutant ALK kinase in human solid tumors |
07/31/2012 | US8231873 Methods of treatment using antibodies to Neutrokine-alpha |
07/31/2012 | US8231866 Cytokine protein family |
07/31/2012 | US8231862 RBP4 in insulin sensitivity/resistance, diabetes, and obesity |
07/31/2012 | CA2532913C Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain |
07/31/2012 | CA2473187C Mismatch endonucleases and methods of use |
07/31/2012 | CA2471656C Antibody against fibroblast growth factor-23 |
07/31/2012 | CA2441925C Novel peptides for the diagnosis of schizophrenia |
07/31/2012 | CA2411919C Immunization of dairy cattle with chimeric gapc protein against streptococcus infection |
07/31/2012 | CA2404688C Nuclear factor .kappa.b inducing factor |
07/31/2012 | CA2372464C Isolating biological modulators from biodiverse gene fragment libraries |
07/31/2012 | CA2370948C Growth factor homolog zvegf4 |
07/31/2012 | CA2362896C Vascular adhesion molecules and modulation of their function |
07/31/2012 | CA2341018C Polypeptides and polynucleotides from coagulase-negative staphylococci |
07/31/2012 | CA2323570C Production of biofilaments in transgenic animals |
07/31/2012 | CA2293736C Synthetic antibiotics |
07/31/2012 | CA2272407C Method and compositions for stimulation of an immune response to a differentiation antigen stimulated by an altered differentiation antigen |
07/31/2012 | CA2223402C Methods of inhibiting phagocytosis |
07/26/2012 | WO2012100196A1 ENHANCED FERMENTATION OF CELLODEXTRINS AND β-D-GLUCOSE |
07/26/2012 | WO2012100010A1 Apolipoprotein aiv as an antidiabetic peptide |
07/26/2012 | WO2012099224A1 Extract of aquatic animal cartilage |
07/26/2012 | WO2012099216A1 Method for mass preparation of proteoglycan |
07/26/2012 | WO2012098449A1 Methods for treating disorders that involve immunoglobulin a |
07/26/2012 | WO2012098413A1 Mutant g-protein coupled receptor proteins and methods for producing them |
07/26/2012 | WO2012098367A1 Delivery of a selectively replicating herpes simplex viral vector to the brain by convection- enhanced delivery (ced) |
07/26/2012 | WO2012098281A2 Trp-receptor-modulating peptides and uses thereof |
07/26/2012 | WO2012098243A1 Homomultimeric structure by assembly of sirv2 p98 proteins or p98 variants, conjugate and uses thereof |
07/26/2012 | WO2012098124A1 Antibodies against the s100p protein for the treatment and diagnosis of cancer |
07/26/2012 | WO2012098113A1 Il-21 ligands |
07/26/2012 | WO2012098009A1 Chimeric polypeptide comprising a membrane protein and an insulin precursor |
07/26/2012 | WO2012097860A1 Novel ubiquitin-isopeptide probes |
07/26/2012 | WO2012097720A1 Highly glyphosate-resistant mutated gene, method of modification and use thereof |
07/26/2012 | WO2012097668A1 Protease of trichoderma reesei and preparation method and usage thereof |
07/26/2012 | WO2012097635A1 NITROGEN ABSORPTION EFFICIENCY AND YIELD IMPROVING RICE GENE OsPTR9 AND USE THEREOF |
07/26/2012 | WO2012097435A1 Immunoreactive francisella tularensis antigens |
07/26/2012 | WO2012069474A3 A method for reducing potential virus burden in a sample by cyanate treatment |
07/26/2012 | WO2012065164A3 Consensus prostate antigens nucleic acid molecule encoding the same and vaccine and uses comprising the same |
07/26/2012 | WO2012060666A3 Method for producing human epidermal growth factor in large volume from yeast |
07/26/2012 | WO2012057527A3 Method for mass production of factor vii/viia |
07/26/2012 | WO2012051372A3 Immunoreactive antigens of mycoplasma heamofelis and diagnostic immunoassay |
07/26/2012 | WO2012047325A3 N-end rule protease activity indication methods and uses thereof |
07/26/2012 | WO2012044048A9 Conductive bio-nano fusion chain and method for preparing same |
07/26/2012 | WO2012042038A3 Chimeric peptides including a penetrating peptide and a binding domain of pp2a catalytic subunit to caspase-9 |
07/26/2012 | WO2012011114A3 Sequence specific double-stranded dna/rna binding compounds and uses thereof |
07/26/2012 | WO2011159826A8 Hcv ns5b polymerase mutants |
07/26/2012 | US20120192314 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene |
07/26/2012 | US20120192310 Novel Bacillus thuringiensis Gene With Lepidopteran Activity |
07/26/2012 | US20120192297 Screening method utilizing thalidomide-targeting factor |
07/26/2012 | US20120190830 Antibody to Human Zcyto-10 Polypeptide |
07/26/2012 | US20120190825 ACETYL LYSINE INCORPORATION WITH tRNA SYNTHETASE |
07/26/2012 | US20120190824 Method for highly sensitive detection of protein-protein interaction |
07/26/2012 | US20120190821 Recombinant soluble fc receptors |
07/26/2012 | US20120190819 Scaffold polypeptides for heterologous peptide display |
07/26/2012 | US20120190818 Triazole macrocycle systems |
07/26/2012 | US20120190814 Thiol Protecting Group |
07/26/2012 | US20120190631 Materials and methods relating to glycosylation |
07/26/2012 | US20120190628 Genes and polypeptides relating to human colon cancers |
07/26/2012 | US20120190626 Amyloid beta fibrillogenesis-inhibiting peptide |
07/26/2012 | US20120190623 Inactivation Resistant Factor VIII |
07/26/2012 | US20120190620 Methods to identify targets and molecules regulating purinosomes and their uses |
07/26/2012 | US20120190616 Analogues of Insulin-Like Growth Factor-1 (IGF-1) Having Amino Acid Substitution at Position 59 |
07/26/2012 | US20120190611 Method for treatment of inflammatory disease and disorder |
07/26/2012 | US20120190610 Tetranectin-apolipoprotein a-i, lipid particles containing it and its use |
07/26/2012 | US20120190609 Method for producing a lipid particle, the lipid particle itself and its use |
07/26/2012 | US20120190579 Functionalisation of Solid Substrates |
07/26/2012 | US20120190576 Glycan Markers as Measure of Disease State of Hepatic Diseases |
07/26/2012 | US20120190569 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
07/26/2012 | US20120190566 Compositions and methods for inhibiting biofilms |
07/26/2012 | US20120190124 Reversible Covalent Linkage of Functional Molecules |
07/26/2012 | US20120190098 Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems |
07/26/2012 | US20120190097 Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same |
07/26/2012 | US20120190096 Materials and methods for conjugating a water soluble fatty acid derivative to a protein |
07/26/2012 | US20120190069 Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium |
07/26/2012 | US20120190058 Method for evaluating cell populations |
07/26/2012 | US20120190051 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
07/26/2012 | US20120190047 Levetiracetam Immunoassays |